| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/01/1993 | WO1993005784A1 Immunopotentiating and infection protective agent and production thereof |
| 04/01/1993 | WO1993005782A1 Sparfloxacine salts and solutions containing same |
| 04/01/1993 | WO1993005776A1 Liquid tolnaftate preparation |
| 04/01/1993 | WO1993005768A1 Medication vehicles made of solid lipid particles (solid lipid nanospheres - sln) |
| 04/01/1993 | WO1993005767A1 Blended lipid vesicles |
| 04/01/1993 | WO1993005766A1 Method of preparing liposomes |
| 04/01/1993 | WO1993005765A1 Pressurised aerosol compositions |
| 04/01/1993 | WO1993005762A1 Utilization in cosmetic or topical applications of an aqueous dispersion based on organopolysiloxanes and a crosslinked copolymer of acrylamide/neutralized 2-acrylamido 2-methylpropane sulfonic acid |
| 04/01/1993 | WO1993005658A1 Targeted cytotoxic effector cells and methods for their production and use |
| 04/01/1993 | WO1992018610A3 Compositions and methods for endothelial binding |
| 04/01/1993 | DE4131878A1 Verfahren zur herstellung von liposomen A process for the preparation of liposomes |
| 04/01/1993 | CA2119578A1 Complex of compound having chalcone skeleton |
| 04/01/1993 | CA2119444A1 Preservative for pharmaceutical products |
| 04/01/1993 | CA2119270A1 Sparfloxacine salts and solutions containing them |
| 04/01/1993 | CA2118595A1 Modified peptide derivatives |
| 03/31/1993 | EP0534860A1 Injectable stabilized solutions containing sparfloxacin or its salts |
| 03/31/1993 | EP0534742A1 Anti-human milk fat globule humanised antibodies |
| 03/31/1993 | EP0534731A1 Pressurised aerosol compositions |
| 03/31/1993 | EP0534615A2 HLA-restricted hepatitis B virus CTL epitopes |
| 03/31/1993 | EP0534445A1 Process for the preparation of a medicament for oral or topical administration in the treatment of leishmaniasis |
| 03/31/1993 | EP0534310A1 Combination containing growth factors and polyelectrolytes |
| 03/31/1993 | EP0534033A1 Method of inhibiting generation, maturation, motility and viability of sperm with minerals in bioavailable form and compositions |
| 03/31/1993 | EP0533938A1 Composition for rectal administration of difficultly absorbable peptide |
| 03/31/1993 | EP0533838A1 Nucleic acid ligands |
| 03/31/1993 | EP0533834A1 Intercellular adhesion mediators |
| 03/31/1993 | EP0533809A1 Polyurethane-biopolymer composite. |
| 03/31/1993 | EP0533799A1 Compositions and methods for the controlled release of soluble active substances. |
| 03/31/1993 | EP0533690A1 Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs |
| 03/31/1993 | EP0533666A1 Use of calcium soap for the treatment of inflammatory skin reactions in horses and ponies |
| 03/31/1993 | EP0451182B1 Pharmaceutical formulations |
| 03/31/1993 | EP0295248B1 Liposome preparation and antibiotic |
| 03/31/1993 | CN1070409A Prodrug activated by targeted catalytic proteins |
| 03/31/1993 | CN1070344A Composition for sustained and controlled release of medicamentous substances and process for preparing same |
| 03/31/1993 | CN1070337A Ointments and ointment preparation |
| 03/31/1993 | CA2079255A1 Long acting injectable formulations containing hydrogenated castor oil |
| 03/30/1993 | US5198470 Lipid compounds derived from sphingosines, process for preparing these and their applications, in particular in cosmetics and in the pharmacy of skin conditions |
| 03/30/1993 | US5198430 Inclusion complexes with silybinin, their preparation and pharmaceutical compositions containing them |
| 03/30/1993 | US5198422 Complex With Aromatic Aldehyde, Sustained Release |
| 03/30/1993 | US5198223 Estrogen/Progesterone, Skin Permeation Enhancer |
| 03/30/1993 | US5198220 Drug delivery, polylactide/glycolide |
| 03/30/1993 | US5198208 Aminopolycarboxylic acids and derivatives thereof |
| 03/30/1993 | CA1315451C Silicone emulsion curable by loss of water to form an elastomer |
| 03/30/1993 | CA1315200C Sustained-release particulate preparation and process for preparing the same |
| 03/30/1993 | CA1315149C Process for the preparation of a sterilised casein-based liquid composition |
| 03/29/1993 | CA2079157A1 Pharmaceutical compositions |
| 03/27/1993 | CA2079042A1 Combination containing growth factors and polyelectrolytes |
| 03/26/1993 | CA2077309A1 Polymeric carriers for release of covalently linked agents |
| 03/25/1993 | DE4131562A1 Arzneistofftraeger aus festen lipidteilchen-feste lipidnanosphaeren (sln) Arzneistofftraeger of solid lipid particles Tight lipidnanosphaeren (sln) |
| 03/24/1993 | EP0533641A2 Coating composition for parts |
| 03/24/1993 | EP0533410A1 Method of administering dipalmitoyl/phosphatidylcholine dispersions |
| 03/24/1993 | EP0533213A1 Use of azelastin and glycerine ethers for the treatment of psoriasis |
| 03/24/1993 | EP0532638A1 Branched polyanhydrides |
| 03/24/1993 | EP0532546A1 A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols |
| 03/24/1993 | EP0532525A1 New protein-polycation conjugates. |
| 03/24/1993 | EP0248040B1 Ricin-antibody conjugates |
| 03/24/1993 | CN1070227A DNA sequences encoding gelonin polypeptide |
| 03/24/1993 | CN1070116A Ion type starch microballs and manufacturing method thereof |
| 03/23/1993 | US5196515 Thiolactone bifunctional chelating agents for diagnostic and therapeutic products |
| 03/23/1993 | US5196510 Polypeptides |
| 03/23/1993 | US5196416 Transdermal flux-enhancing pharmaceutical compositions comprising azone, ethanol and water |
| 03/23/1993 | US5196410 Transdermal flux enhancing compositions |
| 03/23/1993 | US5196406 Cyclodextrin complex of fumagillin derivative |
| 03/23/1993 | US5196320 Method of producing engineered binding proteins |
| 03/23/1993 | US5196199 Hydrophilic form of perfluoro compounds and method of manufacture |
| 03/23/1993 | US5196185 Collagen-based wound dressing and method for applying same |
| 03/23/1993 | US5196184 Spray of Nifedipin, glycerol-polyethyleneglycol oxystearate, benzyl alcohol, ethanol, propellant |
| 03/23/1993 | US5196183 Fatty acid cores encapsulated with human serum albumin |
| 03/18/1993 | WO1993005168A1 Dna sequences encoding gelonin polypeptide |
| 03/18/1993 | WO1993005162A1 Method for delivering nucleic acids into cells |
| 03/18/1993 | WO1993005129A1 Emulsions of polar oils in water |
| 03/18/1993 | WO1993005096A1 Fatty acid terminated polyanhydrides |
| 03/18/1993 | WO1993005032A1 Antimicrobial compositions containing propylene carbonate and/or ethylene carbonate as the carrier solvent |
| 03/18/1993 | WO1993004701A1 Targeted delivery of poly- or oligonucleotides to cells |
| 03/18/1993 | WO1993004691A1 Compositions and methods for treating wounds |
| 03/18/1993 | WO1993004678A1 Antimicrobial preservation of platelets and blood factors |
| 03/18/1993 | WO1993004677A1 Anti-inflammatory analgesic plaster |
| 03/18/1993 | WO1993004676A1 High content ibuprofen agglomerates and process to prepare them |
| 03/18/1993 | WO1993004673A1 Liposomal delivery system with photoactivatable triggered release |
| 03/18/1993 | WO1993004670A1 Dry gel composition |
| 03/18/1993 | DE4125871A1 Dermatological preparations contg. tocopherol and isoprenoid lipid - synergise antibiotics, corticoid(s) and chemotherapeutics in treatment of eczema, allergy and esp. acne |
| 03/18/1993 | CA2116676A1 Method for delivering nucleic acids into cells |
| 03/18/1993 | CA2116549A1 Compositions and methods for treating wounds |
| 03/18/1993 | CA2116107A1 Targeted delivery of poly-or oligonucleotides to cells |
| 03/17/1993 | EP0531611A1 Controlled release matrix for pharmaceuticals |
| 03/17/1993 | EP0531539A1 Lyophilized monoclonal antibody preparation |
| 03/17/1993 | EP0516685A4 Artificial tears |
| 03/17/1993 | EP0513332A4 Conjugates of poly(vinylsaccharide) with proteins for the stabilization of proteins |
| 03/17/1993 | EP0425505B1 Transdermal antisecretory agents for gastrointestinal disease |
| 03/17/1993 | EP0250542B1 Transdermal delivery system |
| 03/17/1993 | CN1069881A Process for antivirus powder without sugar |
| 03/16/1993 | US5194654 Viricides for retroviral infections such as aids |
| 03/16/1993 | US5194594 Conjugation With Heterobifunctional Reagent, Radionucleotide Label |
| 03/16/1993 | US5194581 Biodegradable poly(phosphoesters) |
| 03/16/1993 | US5194473 Modified polyester composition and preparation process and use thereof |
| 03/16/1993 | US5194425 Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
| 03/16/1993 | US5194257 Kit and method for administration of bacillus calmette-guerin for the treatment of superficial bladder tumors |
| 03/16/1993 | US5194254 Antigen coupled to monoclonal antibody |
| 03/16/1993 | CA1314485C Pharmaceutical composition for piperidinoalkanol-decongestant combination |
| 03/16/1993 | CA1314483C Stabilization of 13,14-dihydro-15-ketoprostaglandins |
| 03/16/1993 | CA1314481C Liposomal preparation and antibiotic |